GH Research PLC

Biotechnology • Healthcare • Dublin, Ireland • GHRS (NGM)

GH Research PLC, together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States. Its lead product candidate is GH001, an inhalable mebufotenin product candidate, which is in phase 2b clinical trial for treating patients with treatment-resistant depression; and in phase 2a clinical trial for treating bipolar II disorder and a current major depressive episode, as well as female patients with postpartum depression. The company also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland.

353 1 437 8334 Joshua Dawson House, Ireland

Stock Performance (90 Days)

Data through Dec 29, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Wall Street Analysts Think GH Research (GHRS) Could Surge 130.59%: Read This Before Placing a Bet - Yahoo Finance

Yahoo Finance • Nov 10

GH Research stock rating reiterated at Buy by Stifel amid FDA discussions - Investing.com

Investing.com • Aug 7

GH Research Announces Global Pivotal Program Plans and Further Development Updates - GlobeNewswire

GlobeNewswire • Jul 23

Needham Initiates Coverage of GH Research (GHRS) with Buy Recommendation - Nasdaq

Nasdaq • Oct 13

GH Research (GHRS) Receives a Rating Update from a Top Analyst - The Globe and Mail

The Globe and Mail • Dec 23

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has GH Research PLC had layoffs?

No layoff events have been recorded for GH Research PLC in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

How many employees does GH Research PLC have?

GH Research PLC has approximately 50 employees.

What industry is GH Research PLC in?

GH Research PLC operates in the Biotechnology industry, within the Healthcare sector.

Is GH Research PLC a publicly traded company?

Yes, GH Research PLC is publicly traded under the ticker symbol GHRS on the NGM. The company has a market capitalization of approximately $0.78 billion.

Where is GH Research PLC headquartered?

GH Research PLC is headquartered in Dublin, Ireland at Joshua Dawson House, Ireland.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.